Global Information
회사소개 | 문의 | 위시리스트

지속적 혈당 모니터링 시스템 : 의료기기 파이프라인 평가

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 08월 상품 코드 408771
페이지 정보 영문 309 Pages
가격
US $ 4,000 ₩ 4,792,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,584,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 14,376,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


지속적 혈당 모니터링 시스템 : 의료기기 파이프라인 평가 Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 08월 페이지 정보 : 영문 309 Pages

세계 지속적 혈당 모니터링 시스템(CGM : Glucose Monitoring Systems) 시장의 주요 파이프라인 제품(의료기기)과 임상시험 진행 상황에 대해 조사했으며, 제품 특성 비교 분석(임상시험 진행 단계별), 주요 기업 개요 및 대표적 제품, 최근 시장 동향(자본거래, 사업제휴 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 지속적 혈당 모니터링 시스템 개요

제3장 현재 임상시험 중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 지속적 혈당 모니터링 시스템 : 각 기업에서 현재 임상시험 중인 파이프라인 제품

  • 지속적 혈당 모니터링 시스템 기업 : 임상시험 단계별 파이프라인 제품
  • 지속적 혈당 모니터링 시스템 : 임상시험 단계별 파이프라인 제품

제5장 지속적 혈당 모니터링 시스템 기업 및 제품 개요

  • A. Menarini Diagnostics S.r.l.
  • Abbott Diabetes Care, Inc.
  • Advanced Biosensors-Ohio, Llc
  • Advanced Medical Electronics Corporation
  • Alcon Inc
  • Arkal Medical, Inc.
  • Azurite Technologies, Inc.
  • Bar-Ilan University
  • Bellco Srl
  • Bio-Impedance General Ltd.
  • Biorasis, Inc.
  • BioTex Inc
  • Biovotion AG
  • Brigham and Women's Hospital
  • CALISTO MEDICAL, INC.(Inactive)
  • Cardiff University
  • CGM3 Ltd
  • ConvaTec Healthcare B Sarl
  • Cyber Medical Ltd.
  • Debiotech SA
  • DexCom Inc
  • DirectSens GmbH
  • Eccrine Systems Inc
  • Echo Therapeutics Inc
  • Ecole Polytechnique Federale de Lausanne
  • eLutions Integrated Systems, Inc.
  • EyeSense GmbH
  • Flowsion A/S
  • Globe Medical Tech Inc
  • GlucoLight Corporation
  • Glucometrics, Inc.
  • Glucometrix AG
  • Glucosense Diagnostics Ltd
  • GlucoSet AS
  • Glucovation Inc
  • GluMetrics Inc
  • Glusense Ltd
  • GlySens Inc
  • GlySure Ltd
  • G-Sense Ltd.
  • Guided Therapeutics Inc
  • Hypo-Safe A/S
  • iGlyko, Inc. Company Overview 106
  • Institute of Biomedical Engineering(ISIB-CNR)(Inactive)
  • Insulet Corp
  • Integrity Applications Ltd
  • Invivomon Inc.
  • Invivosense ASA
  • iSense Corporation(Inactive)
  • Luminous Medical Inc
  • Massachusetts Institute of Technology
  • MASTInc
  • Medella Health Inc.
  • Medical Wireless Sensing Ltd
  • Medtronic plc
  • Mellitor Ltd.
  • Microchips Biotech Inc
  • mobiLIFE
  • Nemaura Medical Inc
  • Northwestern University
  • NovioSense B.V.
  • Optiscan Biomedical Corp
  • Pignolo SpA
  • PositiveID Corp
  • Prediktor AS
  • Profusa, Inc.
  • Roche Diagnostics International Ltd
  • San Meditech(Huzhou) Co., Ltd.
  • Senseonics, Incorporated
  • SensiVida Medical Technologies, Inc.(Inactive)
  • Senzime AB
  • Singapore Biomicro Pte
  • Stanford University
  • Tenax Therapeutics Inc
  • Terumo Corp
  • The Charles Stark Draper Laboratory Inc
  • Ultradian Diagnostics LLC
  • University of Bari Aldo Moro
  • University of Bath
  • University of California Berkeley
  • University of California San Diego
  • University of South Florida
  • University of Strathclyde
  • University of Texas at Arlington
  • Vytrace, Inc.
  • Zyvex Corporation

제6장 지속적 혈당 모니터링 시스템 시장 : 최근 동향

제7장 부록

도표

LSH 17.01.04

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
  • Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
  • Table 3: Continuous Glucose Monitoring Systems - Pipeline Product

List of Figures

  • Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
  • Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
  • Figure 3: Continuous Glucose Monitoring Systems - Pipeline Pro

GlobalData's Medical Devices sector report, "Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019", provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Continuous Glucose Monitoring Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Continuous Glucose Monitoring Systems Overview

3 Products under Development

  • 3.1 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
  • 3.2 Continuous Glucose Monitoring Systems - Pipeline Products by Territory
  • 3.3 Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
  • 3.4 Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
  • 3.5 Continuous Glucose Monitoring Systems - Ongoing Clinical Trials

4 Continuous Glucose Monitoring Systems - Pipeline Products under Development by Companies

  • 4.1 Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
  • 4.2 Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development

5 Continuous Glucose Monitoring Systems Companies and Product Overview

  • 5.1 A. Menarini Diagnostics Srl Company Overview
  • 5.2 Abbott Diabetes Care Inc Company Overview
  • 5.3 Advanced Biosensors-Ohio LLC (Inactive) Company Overview
  • 5.4 Advanced Medical Electronics Corp Company Overview
  • 5.5 Arkal Medical, Inc. (Inactive) Company Overview
  • 5.6 Ascensia Diabetes Care Holdings AG Company Overview
  • 5.7 Azurite Technologies, Inc. (Inactive) Company Overview
  • 5.8 Biorasis Inc Company Overview
  • 5.9 Biovotion AG Company Overview
  • 5.10 Brigham and Women's Hospital Company Overview
  • 5.11 CALISTO MEDICAL, INC. (Inactive) Company Overview
  • 5.12 CGM3 Ltd Company Overview
  • 5.13 City, University of London Company Overview
  • 5.14 Columbia University Company Overview
  • 5.15 ConvaTec Group Plc Company Overview
  • 5.16 Cyber Medical Ltd Company Overview
  • 5.17 Debiotech SA Company Overview
  • 5.18 DexCom Inc Company Overview
  • 5.19 DirectSens GmbH Company Overview
  • 5.20 Echo Therapeutics Inc Company Overview
  • 5.21 Ecole Polytechnique Federale de Lausanne Company Overview
  • 5.22 eLutions Integrated Systems, Inc. Company Overview
  • 5.23 EyeSense GmbH Company Overview
  • 5.24 Flowsion A/S Company Overview
  • 5.25 Gili Medical Ltd Company Overview
  • 5.26 Globe Medical Tech Inc (Inactive) Company Overview
  • 5.27 GlucoLight Corporation (Inactive) Company Overview
  • 5.28 Glucometrix AG Company Overview
  • 5.29 Glucosense Diagnostics Ltd (Inactive) Company Overview
  • 5.30 GlucoSet AS Company Overview
  • 5.31 Glucovation Inc Company Overview
  • 5.32 GluMetrics Inc Company Overview
  • 5.33 Glusense Ltd Company Overview
  • 5.34 GlySens Inc Company Overview
  • 5.35 G-Sense Ltd. Company Overview
  • 5.36 iGlyko, Inc. (Inactive) Company Overview
  • 5.37 Indigo Diabetes NV Company Overview
  • 5.38 Innovosens AB Company Overview
  • 5.39 Insulet Corp Company Overview
  • 5.40 Integrated Medical Sensors Company Overview
  • 5.41 Integrity Applications Ltd Company Overview
  • 5.42 Invivosense ASA (Inactive) Company Overview
  • 5.43 I-Sens Inc Company Overview
  • 5.44 iSense Corporation (Inactive) Company Overview
  • 5.45 Keratin Biosciences Inc Company Overview
  • 5.46 Know Labs Inc Company Overview
  • 5.47 KTH Royal Institute of Technology Company Overview
  • 5.48 LEMM Technologies, LLC Company Overview
  • 5.49 Massachusetts Institute of Technology Company Overview
  • 5.50 Medical Wireless Sensing Ltd Company Overview
  • 5.51 Medtronic Diabetes Company Overview
  • 5.52 Medtronic plc Company Overview
  • 5.53 Mellitor Ltd Company Overview
  • 5.54 Metronom Health Inc Company Overview
  • 5.55 mobiLIFE Company Overview
  • 5.56 Nemaura Medical Inc Company Overview
  • 5.57 Newton Photonics Inc Company Overview
  • 5.58 Northwestern University Company Overview
  • 5.59 Orsus Medical Ltd Company Overview
  • 5.60 Pkvitality Company Overview
  • 5.61 PositiveID Corp Company Overview
  • 5.62 Prediktor Medical AS Company Overview
  • 5.63 Profusa Inc Company Overview
  • 5.64 Purdue University Company Overview
  • 5.65 San Meditech (Huzhou) Co., Ltd. Company Overview
  • 5.66 Senseonics Holdings Inc Company Overview
  • 5.67 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
  • 5.68 Senzime AB Company Overview
  • 5.69 Singapore Biomicro Pte Ltd Company Overview
  • 5.70 Socrates Health Solutions, Inc. Company Overview
  • 5.71 Stony Brook University Company Overview
  • 5.72 Swansea University Company Overview
  • 5.73 Tenax Therapeutics Inc Company Overview
  • 5.74 Terumo Corp Company Overview
  • 5.75 Texas A&M University Company Overview
  • 5.76 Ultradian Diagnostics LLC Company Overview
  • 5.77 University of California Berkeley Company Overview
  • 5.78 University of California Irvine Company Overview
  • 5.79 University of California San Diego Company Overview
  • 5.80 University of South Carolina Company Overview
  • 5.81 University of South Florida Company Overview
  • 5.82 University of Technology Sydney Company Overview
  • 5.83 University of Texas at Arlington Company Overview
  • 5.84 VeriTeQ Corporation Company Overview
  • 5.85 Vytrace, Inc. Company Overview
  • 5.86 WaveForm Technologies Inc Company Overview
  • 5.87 Zyvex Corp Company Overview

6 Continuous Glucose Monitoring Systems- Recent Developments

  • 6.1 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
  • 6.2 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
  • 6.3 Jul 18, 2019: Nemaura Medical appoints Chris Avery as vice president of global business operations to support global commercial launch of SugarBEAT
  • 6.4 Jul 17, 2019: Know Labs announces significant pre-clinical progress of uband non-invasive continuous glucose monitor
  • 6.5 Jul 10, 2019: Nemaura Medical submits de novo 510(k) application for SugarBEAT to the U.S. Food and Drug Administration
  • 6.6 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility
  • 6.7 Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps
  • 6.8 Jun 25, 2019: ConvaTec Group: Board Change
  • 6.9 Jun 18, 2019: Senzime contracts new CFO
  • 6.10 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update
  • 6.11 Jun 17, 2019: Abbott reports second-quarter 2019 results
  • 6.12 Jun 11, 2019: Abbott's FreeStyle device helps significantly reduce glucose levels
  • 6.13 Jun 10, 2019: Real-World data from Guardian Connect and Sugar.IQ reveal improved diabetes outcomes
  • 6.14 Jun 08, 2019: Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes
  • 6.15 Jun 08, 2019: Medtronic initiates pivotal trial for next-generation Guardian Continuous Glucose Monitoring Sensor
  • 6.16 Jun 07, 2019: Senzime's board member Ulf Lindskog has passed away
  • 6.17 Jun 06, 2019: Senseonics announces FDA approval for a non-adjunctive indication (Dosing Claim) for the Eversense 90-day CGM System
  • 6.18 Jun 05, 2019: Senseonics to present real-world, long-term safety data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions
  • 6.19 Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q